简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2012-02-02 15:47 Results from Solitaire with the Intention for Thrombectomy (SWIFT) Study Announced at the International Stroke Conference on February 3
2012-02-02 15:26 KCI Announces New Management Structure
2012-02-02 12:50 Covidien Revascularization Device Approved for Interventional Management of Stroke Trial
2012-02-01 12:47 ZELTIQ® Initiates Patent Infringement Lawsuit Against Clinipro
2012-02-01 11:06 BIOTRONIK Successfully Completes Testing of BIOTRONIK EHR DataSync®— Connecting BIOTRONIK Home Monitoring® to Electronic Health Record Systems
2012-01-31 13:54 Covidien Releases Clinical Data on Plaque Excision for the Treatment of Calcified Lesions
2012-01-31 10:50 Clinical Data for DURABILITY II Study Presented at ISET 2012
2012-01-30 16:00 Delphi Genetics: The New DNAVAC Research Project Targets the Removal of Antibiotics in Veterinary DNA-Vaccine Development and Production (Using the Staby® Technology)
2012-01-30 11:54 Covidien CEO Elected Chairman of the Board
2012-01-20 11:21 Covidien Declares Quarterly Cash Dividend
2012-01-19 15:24 Quintiles Joins World-Leading Oncology Experts in Forming New Biomarker Research and Development Company
2012-01-19 11:24 Mirus Biosciences Suit against Fugent Dismissed
2012-01-18 15:12 Quintiles Launches Innovative Center of Excellence in Dalian, China
2012-01-17 17:38 Ferring Pharmaceuticals (Asia) Company Limited Implements Cegedim Relationship Management’s Award Winning* Mobile Intelligence™ CRM Solution & OneKey™ Healthcare Professional Database
2012-01-17 16:23 Covidien Contraindicates the Use of Duet TRSTM for Thoracic Surgery, Implements a Voluntary Recall
2012-01-16 15:50 BIOTRONIK Opens New Asia Pacific Headquarters in Singapore
2012-01-13 16:04 Covidien Appoints Mark Trudeau President of Pharmaceuticals Segment
2012-01-13 15:30 9th Annual BIO Asia International Conference to Feature New Deal Models and Discuss the Future of Innovation in Asia
2012-01-12 15:11 Covidien Donates Additional $1 Million to Support Haitian Hospital
2012-01-11 10:45 ICON Selected by Shire plc’s Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services

Business Wire Weibo

Press Releases

Latest Releases